Trials / Completed
CompletedNCT00452179
Safety and Efficacy Study of APD125 in Patient With Insomnia
A Randomized, Double-Blind, Placebo-Controlled, 3-Way Cross-Over Study to Evaluate the Effects of APD125 in Patients With Chronic Primary Insomnia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 173 (actual)
- Sponsor
- Arena Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to determine the effects of APD125 in patients with sleep maintenance insomnia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | APD125 |
Timeline
- Start date
- 2007-02-01
- Completion
- 2007-06-01
- First posted
- 2007-03-27
- Last updated
- 2007-09-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00452179. Inclusion in this directory is not an endorsement.